KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Cash from Operations (2016 - 2025)

Ionis Pharmaceuticals (IONS) has 17 years of Cash from Operations data on record, last reported at 137709000.0 in Q4 2025.

  • For Q4 2025, Cash from Operations fell 18.57% year-over-year to 137709000.0; the TTM value through Dec 2025 reached 268583000.0, up 46.38%, while the annual FY2025 figure was 268583000.0, 46.38% up from the prior year.
  • Cash from Operations reached 137709000.0 in Q4 2025 per IONS's latest filing, down from 131437000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 203687000.0 in Q4 2021 and bottomed at 200195000.0 in Q4 2022.
  • Average Cash from Operations over 5 years is 66030700.0, with a median of 103193000.0 recorded in 2023.
  • Peak YoY movement for Cash from Operations: tumbled 619.99% in 2021, then surged 226.24% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 203687000.0 in 2021, then tumbled by 198.29% to 200195000.0 in 2022, then soared by 116.42% to 32865000.0 in 2023, then tumbled by 453.38% to 116139000.0 in 2024, then dropped by 18.57% to 137709000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 137709000.0 in Q4 2025, 131437000.0 in Q3 2025, and 151338000.0 in Q2 2025.